Lonza buys Capsugel for $5.5 billion
MLex Summary: Lonza Group has agreed to purchase US drug capsule maker Capsugel from KKR & Co. for $5.5 billion, as the Swiss biotech company seeks to bolster its healthcare business....To view the full article, register now.
Already a subscriber? Click here to view full article